Delivery Order SPE2DB20D3103-SPE2DB24FN6T2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $13,394.72 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for pharmaceutical and medical supply distribution. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,339.41 delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 2, 2020. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award is for pharmaceutical and medical supply products provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $12,497.65 Delivery Order was awarded by the Defense Logistics Agency (DLA) on June 7, 2021, with a completion date of June 8, 2021. The contract is a Firm Fixed Price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $8,430.22 from the Defense Logistics Agency (DLA) for pharmaceutical and medical products. The contract covers a wide range of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply delivery to the Defense Logistics Agency (DLA) under a Delivery Order (DO) valued at $1,074.60. The contract has an ultimate completion date of April 5, 2021 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution to support the U.S. Department of Defense (DoD) and other federal healthcare programs. The contract, a Delivery Order valued at $3,691.80, was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver a range of pharmaceutical products and medical supplies to the U.S. government. The $25,547.09 Firm Fixed Price contract is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of January 16, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,946.28 for pharmaceutical and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of June 18, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- This is a $3,404.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 50mg/25ml vials of the drug doxorubicin liposome, a chemotherapy medication. The award has a completion date of July 7, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of a variety of pharmaceutical products and medical supplies. The $1,068.45 firm fixed-price delivery order has a completion date of May 7, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN6T2Delivery Order
This federal contract award is for the delivery of Doxorubicin Liposome 50mg/25ml pharmaceutical products, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,485.80 Firm Fixed Price Delivery Order has a completion date of May 3, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable the government to efficiently procure essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 5/2/24 |